Drug Development
VIASYS introduces nasal interface product LYRA as legal actions continue
Published in Respiratory Therapeutics Week, August 2nd, 2004
VIASYS earlier filed a complaint against Innomed Technologies Inc. in the U.S. District Court for the Central District of California seeking a declaration that the LYRA product does not infringe a patent that Innomed alleges it owns. While the court dismissed the complaint on procedural grounds, it made no findings on the merits of the case and did not find that the LYRA product infringes Innomed's patent.
Subsequently, Innomed brought a patent infringement action against VIASYS in the U.S. District Court for the Middle District of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
More Articles from Respiratory Therapeutics Week
- Allergies
Report: Dog and cat allergen present in 100% of U.S. homes - Asthma
New 20-year study links COPD and asthma - Asthma
Physicians fail to prescribe proper medication for asthma patients - Pulmonary Lymphangioleiomyomatosis
Low initial KCO predicts rapid FEV1 decline in interstitial disorder - Sclerosing Thymomas
Thymomas can be difficult to diagnose histopathologically - Allergies
Skin prick test for cat allergies now more accurate - More from this issue of Respiratory Therapeutics Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
